Archives
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-04
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2019-06
- 2019-05
- 2019-04
- 2018-11
- 2018-10
- 2018-07
-
Myotubularin 2 Controls Autophagy at Arabidopsis ERES
2026-08-12
This study identifies Arabidopsis Myotubularin 2 (MTM2) as a phosphatidylinositol 3-phosphate phosphatase that localizes to ER exit sites and restrains autophagy. By connecting MTM2 to SEC23A and COPII-dependent secretion, the work reveals how local phosphoinositide turnover coordinates autophagosome formation, protein export, and salt-stress adaptation.
-
Moesin as a Biomarker of Endothelial Injury in Sepsis
2026-08-12
The reference study identifies circulating moesin (MSN) as a candidate indicator of endothelial injury and sepsis severity, linking serum levels with SOFA scores, procalcitonin, and experimental lung damage. Its combination of patient measurements, mouse sepsis models, and endothelial-cell mechanistic experiments supports MSN as both a biomarker candidate and a mediator of barrier dysfunction, while leaving diagnostic validation and therapeutic translation for future work.
-
MLN4924: Selective NEDD8-Activating Enzyme Inhibitor
2026-08-11
MLN4924 is a selective NEDD8-activating enzyme inhibitor that blocks neddylation, suppresses cullin-RING ligase activity, and promotes accumulation of CRL substrates such as CDT1. Its biochemical potency, xenograft activity, and solvent-specific handling profile make it a useful tool for cancer biology research.
-
Crizotinib hydrochloride: Assay Reliability
2026-08-11
Learn how Crizotinib hydrochloride, SKU B3608, supports reproducible viability and signaling studies in ALK-, c-MET-, and ROS1-relevant models. This scenario-driven guide connects compound handling, assembloid design, pathway validation, and practical vendor selection to evidence from recent cancer research.
-
Mechanistic Classification of Aneugenic Chemicals
2026-08-10
The reference study presents a tiered flow-cytometric strategy that distinguishes tubulin destabilization, tubulin stabilization, and mitotic kinase inhibition among aneugenic chemicals. Tested against 27 reference compounds, the workflow combined biomarker profiling with 488-Taxol and p-H3:Ki-67 responses, enabling an artificial neural network to predict molecular targets with 25/26 leave-one-out agreement.
-
EGTA: Precision Calcium Chelation in Cell Models
2026-08-09
EGTA, also called egtazic acid, is an aminopolycarboxylic acid used to reduce free calcium in biochemical and cellular experiments. B7195 is a 98% pure EGTA product intended for calcium signaling, neuroprotection, and endothelial inflammation workflows, but its limited solubility requires careful preparation.
-
Mouse Neutrophil Cell Isolation Kit Guide
2026-08-08
A scenario-driven guide to using Mouse Neutrophil Cell Isolation Kit (Negative Selection), SKU CS1009, for higher-confidence viability, proliferation, and cytotoxicity assays. It explains negative selection, source-specific planning, protocol controls, data interpretation, and practical vendor-selection criteria.
-
MG-132 and Heterochromatin Assay Design
2026-08-07
MG-132 and its synonym Z-LLL-al are widely used to perturb proteasome-dependent protein turnover. This article connects that pharmacology to heterochromatin phase-transition research and shows how to design assays that distinguish proteostasis effects from epigenetic conclusions.
-
miR-122-5p Regulation of PKM2: Mechanistic Insights in Metab
2026-08-07
Zhou et al. dissect the mechanistic role of miR-122-5p in metabolic syndrome, establishing its value as a predictive biomarker and elucidating its regulatory effect on PKM2 and glucose metabolism in hepatic cells. These findings clarify the molecular links between obesity, insulin resistance, and metabolic syndrome, offering technical insights for future biomarker research and experimental design.
-
AZD8055: Technical Guidance for mTOR Inhibitor Applications
2026-08-06
AZD8055 is a potent, selective mTOR inhibitor designed for preclinical research requiring precise modulation of mTORC1 and mTORC2 signaling. It is best suited for studies of cancer cell proliferation, metabolic regulation, and mechanistic pathway interrogation. Due to limited translation in late-stage clinical trials and poor water solubility, it is not recommended for studies requiring clinical efficacy endpoints or aqueous protocols.
-
Applied Workflows with the Cell Senescence β-Galactosidase S
2026-08-06
The Cell Senescence β-Galactosidase Staining Kit empowers researchers with artifact-free detection of senescent cells, streamlining cellular aging assays and senolytic drug discovery. Its robust specificity and user-centric workflow make it indispensable for high-fidelity senescence biomarker detection.
-
PP 3 (SKU B7190): Rigor in Src Kinase Pathway Research
2026-08-05
This article addresses common workflow challenges in Src kinase signaling pathway research and cell-based assay design, focusing on the critical role of 'PP 3' (SKU B7190) as a rigorously validated negative control. Real-world scenarios highlight how APExBIO's PP 3 ensures reproducibility, specificity, and confidence in protein tyrosine kinase inhibition studies.
-
Apigenin: Mechanistic Insights and Translational Impact in O
2026-08-05
Explore the multifaceted mechanisms of Apigenin, a potent 5,7-dihydroxy-2-(4-hydroxyphenyl)chromen-4-one, as both an HDAC inhibitor and neuroprotective flavonoid. This article reveals underexplored mechanistic details and translational strategies, distinguishing itself from prior protocol- or workflow-centric guides.
-
Phalloidin (B7678): Technical Guide for F-Actin Stabilizatio
2026-08-04
Phalloidin (SKU B7678) addresses the need for reliable, high-affinity stabilization and visualization of filamentous actin (F-actin) in fixed or permeabilized samples. It is not suitable for live-cell imaging or for studies requiring reversible actin binding. Researchers should use this reagent for static cytoskeleton analysis where precise preservation of actin architecture is critical.
-
Pronase E (≥7000 U/g): Precision Protease for Ubiquitin-Prot
2026-08-04
Explore how Pronase E, a potent protease mixture, empowers advanced protein sample preparation and mechanistic studies—especially in ubiquitin-proteasome pathway research. This article offers deeper scientific insights and practical guidance on leveraging Pronase E in complex molecular biology workflows.